Aluise, C., Miriyala, S., Noel, T., Sultana, R., Jungsuwadee, P., Taylor, T., … Butterfield, D. (2011). 2-Mercaptoethane sulfonate prevents doxorubicin-induced plasma protein oxidation and TNF-α release: implications for the reactive oxygen species-mediated mechanisms of chemobrain. Free Radical Biology & Medicine, 50(11), 1630-8. https://doi.org/10.1016/j.freeradbiomed.2011.03.009 (Original work published 2011)

Aluise, C., Robinson, R., Cai, J., Pierce, W., Markesbery, W., & Butterfield, D. Redox proteomics analysis of brains from subjects with amnestic mild cognitive impairment compared to brains from subjects with preclinical Alzheimer’s disease: insights into memory loss in MCI. Journal of Alzheimer’s Disease : JAD, 23(2), 257-69. https://doi.org/10.3233/JAD-2010-101083 (Original work published 2011)

Owen, J., Sultana, R., Aluise, C., Erickson, M., Price, T., Bu, G., … Butterfield, D. (2010). Oxidative modification to LDL receptor-related protein 1 in hippocampus from subjects with Alzheimer disease: implications for Aβ accumulation in AD brain. Free Radical Biology & Medicine, 49(11), 1798-803. https://doi.org/10.1016/j.freeradbiomed.2010.09.013 (Original work published 2010)

Aluise, C., Sultana, R., Tangpong, J., Vore, M., St Clair, D., Moscow, J., & Butterfield, D. Chemo brain (chemo fog) as a potential side effect of doxorubicin administration: role of cytokine-induced, oxidative/nitrosative stress in cognitive dysfunction. Advances in Experimental Medicine and Biology, 678, 147-56. https://doi.org/10.1007/978-1-4419-6306-2_19 (Original work published 2010)

Huang, Q., Aluise, C., Joshi, G., Sultana, R., St Clair, D., Markesbery, W., & Butterfield, D. (2010). Potential in vivo amelioration by N-acetyl-L-cysteine of oxidative stress in brain in human double mutant APP/PS-1 knock-in mice: toward therapeutic modulation of mild cognitive impairment. Journal of Neuroscience Research, 88(12), 2618-29. https://doi.org/10.1002/jnr.22422

Aluise, C., Robinson, R., Beckett, T., Murphy, M., Cai, J., Pierce, W., … Butterfield, D. (2010). Preclinical Alzheimer disease: brain oxidative stress, Abeta peptide and proteomics. Neurobiology of Disease, 39(2), 221-8. https://doi.org/10.1016/j.nbd.2010.04.011

Joshi, G., Aluise, C., Cole, M., Sultana, R., Pierce, W., Vore, M., … Butterfield, D. (2010). Alterations in brain antioxidant enzymes and redox proteomic identification of oxidized brain proteins induced by the anti-cancer drug adriamycin: implications for oxidative stress-mediated chemobrain. Neuroscience, 166(3), 796-807. https://doi.org/10.1016/j.neuroscience.2010.01.021 (Original work published 2010)

Aluise, C., St Clair, D., Vore, M., & Butterfield, D. (2009). In vivo amelioration of adriamycin induced oxidative stress in plasma by gamma-glutamylcysteine ethyl ester (GCEE). Cancer Letters, 282(1), 25-9. https://doi.org/10.1016/j.canlet.2009.02.047 (Original work published 2009)

Aluise, C., Sowell, R., & Butterfield, D. (2008). Peptides and proteins in plasma and cerebrospinal fluid as biomarkers for the prediction, diagnosis, and monitoring of therapeutic efficacy of Alzheimer’s disease. Biochimica et Biophysica Acta, 1782(10), 549-58. https://doi.org/10.1016/j.bbadis.2008.07.008